Terrence Bradley
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 44
- Acute Myeloid Leukemia Research 36
- Chronic Myeloid Leukemia Treatments 17
- Multiple Myeloma Research and Treatments 5
- Genetics 24
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Chronic Lymphocytic Leukemia Research 11
- Co-authors
- Naval Daver (10 shared papers)Justin M. Watts (23 shared papers)Gary J. Schiller (4 shared papers)Joseph Maly (4 shared papers)David A. Sallman (14 shared papers)Mark J. Levis (4 shared papers)Ramón V. Tiu (4 shared papers)Alexander E. Perl (4 shared papers)
- Journals
- Blood (22 papers)Journal of Clinical Oncology (6 papers)HemaSphere (3 papers)npj Precision Oncology (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesUnited KingdomPoland
In The Last Decade
Terrence Bradley
46 papers receiving 504 citations
Terrence Bradley's Hit Papers
Peers
Comparison fields: 5 of 32
- Hematology 332
- Genetics 81
- Molecular Biology 259
- Immunology 68
- Oncology 70
Countries citing papers authored by Terrence Bradley
This map shows the geographic impact of Terrence Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terrence Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terrence Bradley more than expected).
Fields of papers citing papers by Terrence Bradley
This network shows the impact of papers produced by Terrence Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terrence Bradley. The network helps show where Terrence Bradley may publish in the future.
Co-authors
The 25 scholars most cited alongside Terrence Bradley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia Hit paper breakdown → | 2022 | 132 |
| 2 | 2020 | 70 | |
| 3 | 2022 | 38 | |
| 4 | 2021 | 35 | |
| 5 | 2019 | 31 | |
| 6 | 2019 | 29 | |
| 7 | 2020 | 23 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2019 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2018 | 7 | |
| 15 | 2020 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2021 | 5 | |
| 19 | 2024 | 4 | |
| 20 | 2020 | 4 |
About Terrence Bradley
Terrence Bradley is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Immunology, having authored 52 papers that have together received 510 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (36 papers), Chronic Myeloid Leukemia Treatments (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Phagocytosis and Immune Regulation (6 papers), Multiple Myeloma Research and Treatments (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Hematology (332 citations), Genetics (81 citations), Molecular Biology (259 citations), Immunology (68 citations) and Oncology (70 citations). Terrence Bradley has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Naval Daver, Justin M. Watts, Gary J. Schiller, Joseph Maly, David A. Sallman, Mark J. Levis, Ramón V. Tiu, Alexander E. Perl, James McCloskey and Mark R. Litzow. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, npj Precision Oncology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.